Tue, May 13, 8:56 PM (41 days ago)
**Elutia Inc. (ELUT) Q1 2025 Financial Summary** **Financial Health:** - **Cash Position:** $17.4 million in cash as of March 31, 2025. - **Debt:** $24.3 million in total indebtedness, including $23.8 million under the SWK Loan Facility. - **Liquidity:** Substantial doubt about the ability to continue as a going concern within one year. **Performance Metrics:** - **Revenue:** $6.03 million, down 9.9% YoY. - **Gross Margin:** 40.7%, down from 42.5% YoY. - **Net Loss:** $3.93 million, improved from $17.99 million YoY. - **Operating Expenses:** $10.38 million, down 8.3% YoY. **Profit Margins:** - **Gross Profit Margin:** 40.7%. - **Operating Margin:** -131.4%. **Cash Flow:** - **Operating Cash Flow:** -$8.88 million. - **Investing Cash Flow:** -$0.28 million. - **Financing Cash Flow:** +$13.28 million. **Earnings Changes:** - **EPS (Basic):** -$0.10, improved from -$0.75 YoY. - **EPS (Diluted):** -$0.21, improved from -$0.75 YoY. **Quarterly Performance:** - **Revenue Growth:** Device Protection up 30.6%, Women’s Health down 26.4%, Cardiovascular down 57.7%. - **Expenses:** Sales and marketing down 8.4%, G&A down 23.4%, R&D down 22.8%, litigation costs up 44.1%. **Trends & Uncertainties:** - **Seasonality:** Historically higher sales in Q4, lower in Q1. - **Legal Proceedings:** Ongoing litigation related to FiberCel and VBM recalls. - **Future Operations:** Plans to expand EluPro offerings and develop new DEB products. **Future Outlook:** - **Funding Needs:** Continued significant expenses and operating losses expected. - **Capital Raising:** May seek additional capital through equity or debt offerings, asset sales, or strategic transactions. - **Risk Factors:** Uncertainties related to product commercialization, litigation, and market acceptance.